We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Stainless Staining Provides New Histology Tool for Researchers and Clinical Pathologists

By LabMedica International staff writers
Posted on 17 May 2015
Researchers have developed a potentially revolutionary system based on infrared spectroscopic imaging that enables stain-free, non-perturbing, multiple analyses of a single biological tissue sample. More...


Histology staining has evolved with non-specific stains, then immunohistochemical staining, and then digital imaging with computerized analysis. In these cases, the prepared biopsy samples are stained. In the new study, a team of engineers, pathologists, and surgeon, led by Prof. Rohit Bhargava of the Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, (Urbana and Champaign, IL, USA), used a new approach, based on Fourier transform infrared (FT-IR) spectroscopic imaging and computation, to develop stain- and label-free chemical imaging to provide the same information as molecular stains. This enables a rapid, digital, quantitative, and non-perturbing visualization of morphology and multiple molecular epitopes for various applications.

The spectra measure the chemical constitution of cells and tissues directly. With computational techniques, the researchers were able to relate spectral properties to known staining patterns of tissue. Using computation and the intrinsic molecular contrast of the tissue enabled molecular stains to be digitally produced without staining the tissue itself. Thus, staining can be visualized while leaving precious tissue pristine for downstream analyses and without the added material cost, time, and labor of direct tissue staining.

This approach also enables analysis of small samples (for example from a thin needle biopsy) or where it may not be possible to obtain multiple samples from the same biopsy for multiple stains. In cases where materials are limited or there may be a need to closely correlate multiple expressed molecules, the new method could be a solution, allowing the user to simply "dial-in" a required stain.

The study is timely as it builds on the emergence of chemical imaging and maturation of computation from the science and engineering side and the drive to greater molecular content information from the biomedical, clinical side. This approach has potential for immediate and long term impact in changing the field to a multiplexed molecular science in research and clinical practice, histology and pathology.

"We're relying on the chemistry to generate the ground truth and act as the "supervisor" for a supervised learning algorithm. A human has to verify that the stain was applied appropriately, but that's something that pathologists do very well", said lead author David Mayerich, assistant professor, University of Houston. Michael Walsh, assistant professor, University of Illinois at Chicago, added, "One of the bottlenecks in automated pathology is the extensive processing that must be applied to stained images to correct for staining artifacts and inconsistencies. The ability to apply stains uniformly across multiple samples could make these initial image processing steps significantly easier and more robust".

"FT-IR imaging allows histology digital imaging without destroying tissue properties caused by staining; therefore, the same slide can be used for other purposes (multiplex immunofluorescence and immunohistochemistry, or other methods). For research applications, it also allows higher throughput by rapidly marking up the tissues for regions of interest," said Dr. Andre Balla. "Infrared and optical imaging seemed to be distinct modes for getting important data in pathology. This study shows a close link between the two, allowing the user to choose the best method to address their needs," said Prof. Bhargava.

The study, by Mayerich D. et al, was published March 20, 2015, in the journal Technology.

Related Links:

University of Illinois at Urbana-Champaign 



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.